Claritev Corp (CTEV) - Forward P/S Multiple

Claritev Health (CTEV) - corporate logo

Regulatory pressure in the US creates a backdrop of uncertainty, yet the operational risks of Claritev Corp (CTEV) remain stable. The company's forward P/S reflects business valuation dynamics, where the 0.50 level serves as a critical benchmark. Growth is driven by moderate pricing power and a tech platform designed to optimize payments. The implementation of AI auditing and diversification through IT services for physicians and employers provide additional resilience.

CTEV (claritev.com) Price to Expected Revenue Ratio history from 03/01/2025 to 11/13/2026

Claritev Health (CTEV) - metric breakdowns and financial figures

- market price and analyst price targets:
Price Chart Claritev|CTEV - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Claritev Health|CTEV - Company Buyout Price
- issuer book value statistics:
Accounting Value per Share Claritev|CTEV - Total Net Assets|Market Capitalization to Book Value Ratio claritev.com|CTEV - Company Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio Claritev Corp|CTEV - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Claritev Corp|CTEV - Aggregate Debt Obligations|Debts to Book Capitalization Claritev Health|CTEV - Company Long-Term Liabilities|Company Short-Term Debt Claritev|Quick Liquidity claritev.com
- net income and valuation multiples indicators:
CTEV - Final Profit|Expected Profit Claritev Corp|CTEV - Market Cap to Net Income|Forward P/E Multiple Claritev Inc.|CTEV - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Claritev Health|CTEV - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Claritev|CTEV - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months claritev.com|CTEV - Earnings per share growth in current year|Net earnings per share growth forecast for next year Claritev Corp
- issuer revenue and sales details:
CTEV - Company Sales|Projected Sales Volume Claritev|CTEV - Price to Sales|Forward P/S Multiple Claritev Health
Summary company analysis:Claritev CTEV
Manufactured products of claritev.com

The market evaluates the investment potential of Claritev Corp (CTEV) through the lens of future cash flows. This metric correlates the current market value of the business with expected revenue for the following year, eliminating reporting time lags. An analysis of the forward price-to-sales ratio allows for an assessment of how IT support outsourcing impacts revenue scalability. This asset falls into the category of companies with moderate operational dependence on external vendors.

Competitors of Claritev Corp (CTEV)

Price-to-Projected Revenue Ratio UnitedHealth UNH|Forward Price to Sales CI|Aflac Insurance - Forward P/S Multiple|Market Cap to Expected Sales Ratio Humana Corp HUM|CNC (Centene Corporation) - Forward Price-to-Revenue Multiple|MOH: Price to Expected Revenue Ratio|MMS (Maximus) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Oscar OSCR|Forward Price-to-Revenue Multiple CLOV (Clover Health Corp)|Price-to-Projected Revenue Ratio YB (Yuanbao Corp)|Health In Tech - Forward Price-to-Revenue Multiple|Forward Price to Sales EHTH|GoHealth - Forward P/S Multiple|NeueHealth, Inc. (NEUE) - Forward Price-to-Revenue Multiple|Reliance Global (RELI) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio MSP Recovery Corp (LIFW)|Price-to-Projected Revenue Ratio MultiPlan Corporation